首页> 外文OA文献 >Caesarean Section Rates and Adverse Neonatal Outcomes After Induction of Labour Versus Expectant Management in Women With an Unripe Cervix: A Secondary Analysis of the HYPITAT and DIGITAT Trials
【2h】

Caesarean Section Rates and Adverse Neonatal Outcomes After Induction of Labour Versus Expectant Management in Women With an Unripe Cervix: A Secondary Analysis of the HYPITAT and DIGITAT Trials

机译:子宫颈未成熟妇女引产与预期管理后剖腹产率和不良新生儿结局:HYPITAT和DIGITAT试验的二级分析

摘要

Between 20% and 25% of pregnancies require induction of labor (IOL), especially in situations that indicate better outcomes for mother and child if the pregnancy is not further prolonged. However, the effectiveness of IOL is subject to considerable debate because of concerns regarding the associated high rates of cesarean deliveries in women with an unripe cervix. The objective of this study was to evaluate the risk of cesarean delivery (CD) and adverse neonatal outcome rates after IOL or expectant management in women with an unripe cervix at or near term. This study used combined data from the multicenter, open-label, randomized controlled trials (RCTs) HYPITAT and DIGITAT. The inclusion criteria were women with hypertensive disease (HYPITAT trial) or suspected fetal growth restriction (DIGITAT trial) and a Bishop score of 6 or less. The study compared the outcomes after IOL and expectant management. The primary outcomes of this study were CD and a composite adverse neonatal outcome (defined as 5-minute Apgar score Results of the study revealed that of 1172 women with an unripe cervix 572 women had IOL and 600 women had expectant management. It was noted that there was no significant difference in the overall CD rate (difference, -1.1%; 95% CI, -5.4 to 3.2). Also, IOL did not increase CD rates in women with Bishop scores from3 to 6 (difference, -2.7%; 95% CI, -7.6 to 2.2) or adverse neonatal outcome rates (difference, -1.5%; 95% CI, -4.3 to 1.3). Results, however, noted that there was a significant difference in the rates of arterial umbilical cord pH less than 7.05 favoring IOL (difference, -3.2%; 95% CI, -5.6 to -0.9). The study concludes that there is no evidence that IOL increases the CD rate or compromises neonatal outcome as compared with expectant management in term or near-term pregnancies complicated by intrauterine growth restriction (IUGR), gestational hypertension, or preeclampsia. In addition, it was noted that there is no basis for concern regarding any increase in risk of failed induction in women with a Bishop score from 3 to 6.
机译:孕妇中有20%至25%需要引产(IOL),尤其是在如果怀孕时间不再延长的情况下,对母子的预后较好的情况。然而,由于担心未成熟子宫颈妇女的剖宫产率较高,因此人工晶体的有效性尚需进行大量辩论。这项研究的目的是评估IOL或宫颈未成熟妇女的IOL或预期处理后剖宫产(CD)的风险和不利的新生儿结局发生率。这项研究使用了来自HYPITAT和DIGITAT的多中心,开放标签,随机对照试验(RCT)的组合数据。纳入标准为患有高血压疾病(HYPITAT试验)或怀疑胎儿生长受限(DIGITAT试验)且Bishop得分为6或更低的女性。该研究比较了人工晶体和预期管理后的结果。这项研究的主要结局是CD和新生儿综合不良结局(定义为5分钟Apgar评分)。研究结果显示,在1172例未成熟宫颈的妇女中,有572例发生了人工晶体,而600例则进行了预期的治疗。总体CD率无显着差异(差异为-1.1%; CI为95%,-5.4至3.2);而且,Bishop评分从3增至6的女性,IOL并未使CD比率增加(差异为-2.7%; 95%CI,-7.6至2.2)或不利的新生儿结局发生率(差异,-1.5%; 95%CI,-4.3至1.3),但结果显示,动脉脐带pH值存在显着差异小于7.05有利于人工晶体(差异,-3.2%; 95%CI,-5.6至-0.9)。研究得出的结论是,没有证据表明与预期管理相比,人工晶体会增加CD率或损害新生儿结局足月妊娠并发宫内生长受限(IUGR),妊娠高血压或p子痫。此外,有人指出,Bishop分数从3增至6的女性中,归纳失败的风险是否增加,没有理由值得关注。

著录项

相似文献

  • 外文文献
  • 中文文献

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号